Corporate profits versus spending on non-communicable disease prevention: an unhealthy balance

Lancet Glob Health. 2019 Nov;7(11):e1482-e1483. doi: 10.1016/S2214-109X(19)30399-7.

Authors

Luke N Allen¹, Arian Hatefi², Andrea B Feigl³

Affiliations

¹ Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK. Electronic address: luke.allen@phc.ox.ac.uk.
² Division of Hospital Medicine, Department of Medicine, Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
³ Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA.

PMID: 31607454
DOI: 10.1016/S2214-109X(19)30399-7

No abstract available

MeSH terms

Advertising / economics*
Advertising / statistics & numerical data
Commerce / economics*
Commerce / organization & administration
Fast Foods / economics
Food Industry / economics*
Health Policy / economics
Humans
Industry / economics
Noncommunicable Diseases / economics*
Noncommunicable Diseases / epidemiology
Organizational Culture
Public Health / economics
Tobacco Industry / economics